Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
NRIX
#1905
Nurix Therapeutics, Inc. Common stock
15.970
0
+2.70%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+2.70%
Variazione Mensile
-18.42%
Variazione di 6 mesi
+42.46%
Variazione Annuale
+42.46%
Chiusura Precedente
15.550
0
Open
15.970
0
Bid
Ask
Low
15.970
0
High
15.970
0
Volume
162
Mercati
Mercato Azionario Statunitense
Salute
NRIX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.91 M
44.74 M
47.27 M
48.89 M
75.89 M
102.84 M
—
Valuation ratios
Enterprise value
1.54 B
1.21 B
521.24 M
249.49 M
1.52 B
1.49 B
4.06 B
Price to earnings ratio
—
—
-3.34
-2.35
-7.46
-5.54
-18.83
Price to sales ratio
—
—
15.59
4.39
26.44
17.45
56.77
Price to cash flow ratio
—
—
3.77
4.15
8.36
5.87
19.16
Price to book ratio
—
—
1.98
1.69
2.74
2.72
4.24
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.25
0.43
0.4
0.29
0.38
0.44
Return on equity %
0.15
0.34
0.59
0.72
0.37
0.49
0.59
Return on invested capital %
132.86
270.56
403.07
629.36
713.83
923.04
904.34
Gross margin %
100
100
100
100
100
100
400
Operating margin %
364.66
396.26
476.01
201.41
390.52
340.16
2 220.03
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
242.66
393.93
466.93
186.98
354.85
314.9
2 074.93
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.7
4.7
4.51
3.4
6.46
7.02
25.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.07
0.09
0.2
0.11
0.12
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
3.29
1.5
2.57
2.88
2.95
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.36
5.3
9.08
6.84
24.31
Net current asset value per share
—
—
6.55
5.44
9.23
7
25.13
Tangible book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Working capital per share
—
—
5.1
3.84
7.8
6
21.17
Book value per share
—
—
6.25
3.69
7.85
6.22
21.73
Notizie
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Ring Christine, direttore legale di Nurix, vende azioni NRIX per 237 mila dollari
Il direttore legale di Nurix Therapeutics vende azioni per 73mila dollari
Nurix Therapeutics CFO Hans van Houte sells $61k in shares
Nurix Therapeutics chief legal officer Ring sells $73k in stock
Nurix Therapeutics: CSO Gwenn Hansen vende azioni per 81.000 dollari
Nurix Therapeutics CSO Gwenn Hansen sells $81k in shares
Stifel alza il target di prezzo delle azioni Nurix a $35 per il potenziale di bexobrutideg
Stifel raises Nurix stock price target to $35 on bexobrutideg potential
Piper Sandler alza il target di prezzo delle azioni Nurix a 35$ sui piani di trial pivotali
Piper Sandler raises Nurix stock price target to $35 on pivotal trial plans
H.C. Wainwright alza il target di prezzo delle azioni Nurix a $32 dopo i risultati finanziari